Skip to main content
Clinical Trials/JPRN-UMIN000002736
JPRN-UMIN000002736
Completed
Phase 1

A multi-centric Phase II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer - Phase II study of IP docetaxel with S-1 for peritoneal dissemination

Society for the Study of Peritoneal Dissemination in Gastric Cancer0 sites50 target enrollmentNovember 11, 2009

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
primary gastric cancer with peritoneal dissemination
Sponsor
Society for the Study of Peritoneal Dissemination in Gastric Cancer
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2009
End Date
December 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Society for the Study of Peritoneal Dissemination in Gastric Cancer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Severe medical condition 2\. Malignant tumors of other organs 3\. massive pleural effusion/ascites

Outcomes

Primary Outcomes

Not specified

Similar Trials